NURIX THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
NURIX THERAPEUTICS, INC. (NRIX) had Common Stock, Capital Shares Reserved for Future Issuance of 30.85 million shares as of 2026-05-31, per its 10-Q filed 2026-07-09.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-07-09
- 2026-05-31: Common Stock, Capital Shares Reserved for Future Issuance 30.85M shares.
- 2026-02-28: Common Stock, Capital Shares Reserved for Future Issuance 31.15M shares.
- 2025-11-30: Common Stock, Capital Shares Reserved for Future Issuance 26.65M shares.
- 2025-08-31: Common Stock, Capital Shares Reserved for Future Issuance 27.10M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-05-31 | 30.85M shares 10-Q · filed 2026-07-09 |
| 2026-02-28 | 31.15M shares 10-Q · filed 2026-04-08 |
| 2025-11-30 | 26.65M shares 10-Q · filed 2026-07-09 |
| 2025-08-31 | 27.10M shares 10-Q · filed 2025-10-09 |
| 2025-05-31 | 27.54M shares 10-Q · filed 2025-07-09 |
| 2025-02-28 | 27.74M shares 10-Q · filed 2025-04-08 |
| 2024-11-30 | 24.31M shares 10-K · filed 2026-01-28 |
| 2024-08-31 | 21.66M shares 10-Q · filed 2024-10-11 |
| 2024-05-31 | 22.24M shares 10-Q · filed 2024-07-11 |
| 2024-02-29 | 20.85M shares 10-Q · filed 2024-04-10 |
| 2023-11-30 | 18.83M shares 10-K · filed 2025-01-28 |
| 2023-08-31 | 19.04M shares 10-Q · filed 2023-10-12 |
| 2023-05-31 | 19.92M shares 10-Q · filed 2023-07-13 |
| 2023-02-28 | 20.10M shares 10-Q · filed 2023-04-13 |
| 2022-11-30 | 18.02M shares 10-K · filed 2024-02-15 |
| 2022-08-31 | 18.04M shares 10-Q · filed 2022-10-06 |
| 2022-05-31 | 11.33M shares 10-Q · filed 2022-07-07 |
| 2022-02-28 | 11.52M shares 10-Q · filed 2022-04-08 |
| 2021-11-30 | 9.48M shares 10-K · filed 2023-02-09 |
| 2021-08-31 | 9.56M shares 10-Q · filed 2021-10-14 |
| 2021-05-31 | 9.74M shares 10-Q · filed 2021-07-13 |
| 2021-02-28 | 9.85M shares 10-Q · filed 2021-04-13 |
| 2020-12-31 | 1.55M shares 10-K · filed 2021-02-16 |
| 2020-11-30 | 8.15M shares 10-K · filed 2022-01-28 |
| 2020-08-31 | 8.17M shares 10-Q · filed 2020-10-14 |
| 2019-11-30 | 15.14M shares 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |